- Home
- VEEA vs CLYM Comparison
VEEA vs CLYM Comparison
Compare VEEA & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEA
- CLYM
- Stock Information
- Founded
- VEEA 2014
- CLYM 2018
- Country
- VEEA United States
- CLYM United States
- Employees
- VEEA N/A
- CLYM N/A
- Industry
- VEEA
- CLYM
- Sector
- VEEA
- CLYM
- Exchange
- VEEA NYSE
- CLYM NYSE
- Market Cap
- VEEA 112.2M
- CLYM 101.6M
- IPO Year
- VEEA N/A
- CLYM 2021
- Fundamental
- Price
- VEEA $1.56
- CLYM $1.28
- Analyst Decision
- VEEA
- CLYM
- Analyst Count
- VEEA 0
- CLYM 0
- Target Price
- VEEA N/A
- CLYM N/A
- AVG Volume (30 Days)
- VEEA 22.7K
- CLYM 183.8K
- Earning Date
- VEEA 05-23-2025
- CLYM 03-25-2025
- Dividend Yield
- VEEA N/A
- CLYM N/A
- EPS Growth
- VEEA N/A
- CLYM N/A
- EPS
- VEEA N/A
- CLYM N/A
- Revenue
- VEEA $140,035.00
- CLYM N/A
- Revenue This Year
- VEEA N/A
- CLYM N/A
- Revenue Next Year
- VEEA N/A
- CLYM N/A
- P/E Ratio
- VEEA N/A
- CLYM N/A
- Revenue Growth
- VEEA N/A
- CLYM N/A
- 52 Week Low
- VEEA $1.33
- CLYM $1.20
- 52 Week High
- VEEA $18.56
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- VEEA N/A
- CLYM N/A
- Support Level
- VEEA N/A
- CLYM N/A
- Resistance Level
- VEEA N/A
- CLYM N/A
- Average True Range (ATR)
- VEEA 0.00
- CLYM 0.00
- MACD
- VEEA 0.00
- CLYM 0.00
- Stochastic Oscillator
- VEEA 0.00
- CLYM 0.00
Stock Price Comparison Chart: VEEA vs CLYM
About VEEA VEEA INC
Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.